跳至主要内容
临床试验/NCT03208361
NCT03208361终止3 期

Efficacy of High Doses of Oral Penicillin V Versus High Doses of Oral Amoxicillin in the Treatment of Non-severe Community-acquired Pneumonia in Adults

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina1 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2013年11月5日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
终止
发起方
入组人数
43
试验地点
1
主要终点
Disappearance or improvement of cough

研究概览

简要总结

This study aims to evaluate wether high-dose penicillin V is as effective as high-dose amoxicillin for the treatment of non-sever community-acquired pneumonia (CAP).

详细描述

Phase III parallel-group, randomised, double blind clinical trial, performed in 31 primary healthcare centres in Spain.

The use of narrow-spectrum antibiotics is needed because of the dearth of new antimicrobials and the link observed between the consumption of broad-spectrum antibiotics and the emergence and spread of antibacterial resistance.

Objective: The aim of the present trial was to determine whether high-dose penicillin V was as effective as high-dose amoxicillin for the treatment of uncomplicated CAP in a Mediterranean adult population.

Subjects: Patients between 18-75 years with lower respiratory tract infection and radiologically confirmed diagnosis of pneumonia.

Primary outcome: Clinical resolution at day 14

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients 18 years to 75 years (inclusive).
  • Signs and symptoms of lower respiratory tract infection.
  • Radiological confirmation of the diagnosis of pneumonia or not radiological confirmation but the patient has the following symptoms: high fever (> 38.5 ° C), cough and purulent sputum and auscultation of crackles in a pulmonary focus, the researcher undertakes to confirm after inclusion pneumonia with mandatory radiological study.
  • Signature of informed consent.

排除标准

  • Impaired consciousness: confused state, delirium, drowsiness, stupor or coma, at the discretion of the investigator
  • Respiratory rate> 30 breaths / minute
  • Heart rate> 125 beats / minute
  • Systolic blood pressure <90 mm ??Hg or diastolic BP <60 mm Hg
  • Hypersensitivity to beta-Lactamics
  • O2 saturation <92%
  • Axillary temperature> 40 ° C
  • bronchial Asthma
  • Pregnancy or lactation
  • Significant comorbidities: renal failure, liver cirrhosis, heart failure, chronic obstructive pulmonary disease, ischemic heart disease diagnosed less than 6 months, stroke diagnosed less than 6 months ago and / or type 1 diabetes mellitus
  • Significant alteration in chest radiography: alveolar infiltrates in more than one lobe or bilateral pleural effusion or pulmonary cavitation
  • Problems to meet the treatment at home: sociopathy or psychiatric problems, drug and alcohol addiction, or, an unsuitable family environment
  • Lack of tolerance to oral therapy: presence of nausea and vomiting, gastrectomy, post-surgery or frank diarrhea
  • Immunosuppression: chronic HIV infection, transplant, neutropenic, or, patients receiving immunosuppressive therapy
  • active malignancy
  • terminal disease
  • Hospitalization in the last month
  • Taking any systemic antibiotic in the previous three days or a full use of oral antibiotics prior to inclusion in the previous two weeks (use of urinary antiseptics is not a reason for exclusion).
  • Difficulty to attend follow-up visits
  • Refusal to participate in the study

研究组 & 干预措施

Penicillin V

Experimental

Penicillin V, 1600000 IU every 8h during 10 days.

干预措施: Penicillin V (Drug)

Amoxicillin

Active Comparator

Amoxicillin, 1 g every 8h during 10 days.

干预措施: Amoxicillin (Drug)

结局指标

主要结局

Disappearance or improvement of cough

时间窗: 14 days after inclusion

Disappearance or improvement of cough (included in the general definition of Clinical Cure)

Improvement of general condition

时间窗: 14 days after inclusion

Improvement of general condition (included in the general definition of Clinical Cure)

Disappearance of fever

时间窗: 14 days after inclusion

Disappearance of fever (included in the general definition of Clinical Cure)

Disappearance or reduction of auscultation of crackles

时间窗: 14 days after inclusion

Disappearance or reduction of auscultation of crackles (included in the general definition of Clinical Cure)

No other antimicrobial treatment necessary

时间窗: 14 days after inclusion

No other antimicrobial treatment necessary (included in the general definition of Clinical Cure

次要结局

  • Radiological resolution(30 days after inclusion)
  • Adverse Events(1-30 days)
  • No other antimicrobial treatment necessary(30 days after inclusion)
  • Total Clinical Resolution(30 days after inclusion)
  • Disappearance of fever(30 days after inclusion)
  • disappearance or improvement of cough(30 days after inclusion)
  • improvement of general condition(30 days after inclusion)
  • disappearance or reduction of auscultation of crackles(30 days after inclusion)

研究者

发起方
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Efficacy of High Doses Penicillin V Versus High... | 临床试验